Replies to post #19397 on Ariad Pharmaceuticals Inc fka ARIA

[DewDiligence]

I still think that the possible loss of the huge Gleevec income stream is a huge incentive for Novartis to explore acquiring Ariad.

Should NVS just forget about Tasigna??

[binchey]

Novartis has another alternative, old but relevant link -> http://mobile.reuters.com/article/idUSL6E7NC3AX20111212?irpc=932